First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis

Blood Purif. 2001;19(2):260-3. doi: 10.1159/000046952.
No abstract available

Publication types

  • Evaluation Study

MeSH terms

  • Adsorption
  • Adult
  • Amyloidosis / etiology
  • Amyloidosis / prevention & control*
  • Anticoagulants / administration & dosage
  • Blood Cell Count
  • Blood Coagulation Tests
  • Coated Materials, Biocompatible
  • Equipment Design
  • Hemoperfusion / instrumentation*
  • Heparin / administration & dosage
  • Humans
  • Infusions, Intravenous
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy
  • Male
  • Microspheres
  • Middle Aged
  • Polymers
  • Polystyrenes
  • Povidone
  • Renal Dialysis / adverse effects
  • Renal Dialysis / instrumentation*
  • Serum Albumin / analysis
  • Sorption Detoxification / instrumentation*
  • Sulfones
  • Uremia / blood
  • Uremia / complications
  • Uremia / therapy*
  • beta 2-Microglobulin / analysis*

Substances

  • Anticoagulants
  • Coated Materials, Biocompatible
  • Polymers
  • Polystyrenes
  • Serum Albumin
  • Sulfones
  • beta 2-Microglobulin
  • polysulfone P 1700
  • Heparin
  • Povidone